patients | IPF(N = 96) | Control(N = 50) | T/F | P |
---|---|---|---|---|
Mean age(range) | 61 ± 7 | 58 ± 6 | 2.819 | 0.057 |
Gender, male, n (%) | 92(95.8%) | 46(92.0%) | 0.002 | 0.962 |
Smoking, n (%) | 80(83.3%) | 16(32.0%) | 4.587 | <0.001 |
Height(cm) | 168.1 ± 5.9 | 169.5 ± 6.4 | -1.370 | 0.173 |
Weight(kg) | 72.9 ± 9.1 | 71.00 ± 8.2 | 1.259 | 0.210 |
BMI(m/kg2) | 25.8 ± 2.6 | 24.7 ± 2.3 | 1.792 | 0.077 |
TLV on HRCT (L) | 4.3 ± 0.9 | 4.7 ± 0.5 | -2.511 | 0.013 |
Pulmonary function | ||||
FVC % predicted | 82.9 ± 16.6 | 103.3 ± 11.0 | -7.895 | <0.001 |
FEV1% predicted | 86.0 ± 15.8 | 99.1 ± 12.5 | -5.118 | <0.001 |
FEV1/FVC% predicted | 82.6 ± 5.9 | 83.1 ± 9.9 | -0.340 | 0.734 |
TLC% predicted | 69.4 ± 13.9 | 98.5 ± 9.7 | -13.325 | <0.001 |
DLCO % predicted | 54.9 ± 17.3 | 100.0 ± 14.1 | -15.976 | <0.001 |
6MWD(m) | 495.5 ± 74.7 | 775.6 ± 49.5 | -12.405 | < 0.001 |
Resting dyspnea (MRC), n (%) | ||||
1 | 46(47.9%) | \ | Â | Â |
2 | 40(41.7%) | \ | Â | Â |
3 | 10(10.4%) | \ | Â | Â |
4 | 0 | \ | Â | Â |
5 | 0 | \ | Â | Â |
HRQoL | Â | Â | Â | Â |
Respiratory symptoms | 42.6 ± 23.7 | \ |  |  |
Activity | 51.8 ± 74.3 | \ |  |  |
Psychosocial impact | 19.5 ± 17.6 | \ |  |  |
Total | 30.0 ± 17.3 | \ |  |  |
GAP score, n (%) | Â | Â | Â | Â |
I | 66(45.2%) | \ | Â | Â |
II | 26(17.8%) | \ | Â | Â |
III | 4(2.7%) | \ | Â | Â |
HRCT, n (%) | Â | Â | Â | Â |
UIP | 78(81.3%) | \ | Â | Â |
Possible UIP | 18(18.7%) | \ | Â | Â |
The percentage of ILD findings on HRCT | Â | Â | Â | |
GGO (%) | 0.18 ± 0.9 | \ |  |  |
Reticulation (%) | 11.1 ± 8.9 | \ |  |  |
Honeycombing (%) | 8.7 ± 10.3 | \ |  |  |
Pulmonary fibrosis (%) | 19.8 ± 11.3 | \ |  |  |